T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection
暂无分享,去创建一个
C. Weaver | J. Langhorne | A. O’Garra | P. S. Redford | N. Ghilardi | Craig L. Maynard | E. Stavropoulos | Paul S. Redford | Xuemei Wu | Lúcia Moreira-Teixeira | A. P. Freitas do Rosário
[1] R. Appelberg,et al. Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling , 2016, The Journal of Immunology.
[2] Rachel P. J. Lai,et al. Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection , 2015, The Journal of experimental medicine.
[3] A. Sher,et al. Type I interferons in infectious disease , 2015, Nature Reviews Immunology.
[4] Anna R Martirosyan,et al. Type I IFN Induces IL-10 Production in an IL-27–Independent Manner and Blocks Responsiveness to IFN-γ for Production of IL-12 and Bacterial Killing in Mycobacterium tuberculosis–Infected Macrophages , 2014, The Journal of Immunology.
[5] Andrea De Maria,et al. Immunology of Tuberculosis , 2014, Mediterranean journal of hematology and infectious diseases.
[6] A. O’Garra,et al. The regulation of IL-10 expression. , 2014, Current topics in microbiology and immunology.
[7] M. Jordana,et al. Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells , 2013, Mucosal Immunology.
[8] D. Chaussabel,et al. TPL-2–ERK1/2 Signaling Promotes Host Resistance against Intracellular Bacterial Infection by Negative Regulation of Type I IFN Production , 2013, The Journal of Immunology.
[9] Robert J Wilkinson,et al. The immune response in tuberculosis. , 2013, Annual review of immunology.
[10] G. Beamer,et al. Clonal Expansions of CD8+ T Cells with IL-10 Secreting Capacity Occur during Chronic Mycobacterium tuberculosis Infection , 2013, PloS one.
[11] G. Beamer,et al. IL-10 Inhibits Mature Fibrotic Granuloma Formation during Mycobacterium tuberculosis Infection , 2013, The Journal of Immunology.
[12] G. Bancroft,et al. Blockade of IL-10 Signaling during Bacillus Calmette-Guérin Vaccination Enhances and Sustains Th1, Th17, and Innate Lymphoid IFN-γ and IL-17 Responses and Increases Protection to Mycobacterium tuberculosis Infection , 2012, The Journal of Immunology.
[13] Werner Müller,et al. IL-27 Promotes IL-10 Production by Effector Th1 CD4+ T Cells: A Critical Mechanism for Protection from Severe Immunopathology during Malaria Infection , 2012, The Journal of Immunology.
[14] A. Sher,et al. Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. , 2011, Immunity.
[15] J. Keane,et al. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. , 2011, American journal of respiratory cell and molecular biology.
[16] A. O’Garra,et al. The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.
[17] Jingxian Zhao,et al. Highly Activated Cytotoxic CD8 T Cells Express Protective IL-10 at the Peak of Coronavirus-Induced Encephalitis , 2011, The Journal of Immunology.
[18] G. Bancroft,et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.
[19] H. Mollenkopf,et al. The adaptor molecule CARD9 is essential for tuberculosis control , 2010, The Journal of experimental medicine.
[20] Margarida Saraiva,et al. The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.
[21] C. Leclerc,et al. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. , 2009, Immunity.
[22] C. Hunter,et al. IL-27 Regulates IL-10 and IL-17 from CD4+ Cells in Nonhealing Leishmania major Infection1 , 2009, The Journal of Immunology.
[23] S. Ehlers,et al. Autocrine IL-10 Induces Hallmarks of Alternative Activation in Macrophages and Suppresses Antituberculosis Effector Mechanisms without Compromising T Cell Immunity1 , 2009, The Journal of Immunology.
[24] H. Bang,et al. Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity1 , 2009, The Journal of Immunology.
[25] A. Cooper,et al. Cell-mediated immune responses in tuberculosis. , 2009, Annual review of immunology.
[26] I. Orme,et al. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. , 2009, Tuberculosis.
[27] T. Braciale,et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10 , 2009, Nature Medicine.
[28] D. Flaherty,et al. Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.
[29] Y. Belkaid,et al. IL-10 from CD4+CD25−Foxp3−CD127− Adaptive Regulatory T Cells Modulates Parasite Clearance and Pathology during Malaria Infection , 2008, PLoS pathogens.
[30] A. Rudensky,et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3− precursor cells in the absence of interleukin 10 , 2007, Nature Immunology.
[31] B. Reizis,et al. Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.
[32] I. Orme,et al. The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.
[33] S. Kaufmann,et al. Cutting Edge: Regulatory T Cells Prevent Efficient Clearance of Mycobacterium tuberculosis , 2007, The Journal of Immunology.
[34] D. Sacks,et al. CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis , 2007, The Journal of experimental medicine.
[35] Richard A. Flavell,et al. Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection , 2007, The Journal of experimental medicine.
[36] Werner Müller,et al. Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA , 2006, European journal of immunology.
[37] J. Casanova,et al. Tuberculosis in children and adults , 2005, The Journal of experimental medicine.
[38] B. Trapnell,et al. Disruption of granulocyte macrophage‐colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection , 2005, Journal of leukocyte biology.
[39] T. Mak,et al. The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis 1 , 2005, The Journal of Immunology.
[40] S. Khader,et al. IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice1 , 2004, The Journal of Immunology.
[41] K. Rajewsky,et al. T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation , 2004, The Journal of experimental medicine.
[42] J. Casanova,et al. Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. , 2004, The Journal of infectious diseases.
[43] N. Boéchat,et al. Down-Modulation of Lung Immune Responses by Interleukin-10 and Transforming Growth Factor β (TGF-β) and Analysis of TGF-β Receptors I and II in Active Tuberculosis , 2004, Infection and Immunity.
[44] Yu-Jin Jung,et al. Increased interleukin‐10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice , 2003, Immunology.
[45] R. North,et al. Immunity to tuberculosis. , 2003, Annual review of immunology.
[46] M. Newport,et al. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. , 2002, The Journal of infectious diseases.
[47] I. Orme,et al. In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.
[48] W. M. Weaver,et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. , 2001, Immunity.
[49] Joseph Keane,et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .
[50] M. Geletu,et al. Circulating TNF‐α, TGF‐β, and IL‐10 in Tuberculosis Patients and Healthy Contacts , 2001, Scandinavian journal of immunology.
[51] F.J. Sauvage,et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR , 2000, Nature.
[52] G. Trinchieri,et al. CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .
[53] W. Reith,et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.
[54] N. Juffermans,et al. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment , 1999, Clinical and experimental immunology.
[55] R. North. Mice incapable of making IL‐4 or IL‐10 display normal resistance to infection with Mycobacterium tuberculosis , 1998, Clinical and experimental immunology.
[56] I. Orme,et al. Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.
[57] J. Mudgett,et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[58] K. Rajewsky,et al. B lymphocyte-specific, Cre-mediated mutagenesis in mice. , 1997, Nucleic acids research.
[59] M. Newport,et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.
[60] P. Linsley,et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression , 1996, Infection and immunity.
[61] J. Flynn,et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. , 1995, Journal of immunology.
[62] C. Lowenstein,et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.
[63] Alan D. Roberts,et al. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. , 1995, Immunology.
[64] Dinakar,et al. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. , 1994, The Journal of clinical investigation.
[65] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[66] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[67] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[68] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[69] J. Abrams,et al. Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.
[70] M. de Carli,et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. , 1993, Journal of immunology.
[71] J. Casanova,et al. Tuberculosis in children and adults: two distinct genetic diseases , 2005 .
[72] I. Orme,et al. Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice , 2022 .
[73] J. Casanova,et al. Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.
[74] J. Keane,et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.
[75] Ichael,et al. A MUTATION IN THE INTERFERON- g –RECEPTOR GENE AND SUSCEPTIBILITY TO MYCOBACTERIAL INFECTION , 2000 .
[76] G. Trinchieri,et al. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. , 1999, Clinical immunology.